Skip to search.
 TSX Up 0.87% TSX Ventures Up 0.73%

VIVUS Inc. (VVUS)

-NasdaqGS
2.58 May 21, 4:00PM EDT
Add to Portfolio
Prev Close:2.58
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:4.00
Beta:1.17
Earnings Date:Aug 5 - Aug 10 (Est.)
Day's Range:N/A - N/A
52wk Range:2.22 - 5.52
Volume:0
Avg Vol (3m):1,964,990
Market Cap:267.85M
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VVUS 0.00%267.85M
LLY78.65B
GSK110.03B
PFE211.58B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.44
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.86
Quarterly EPS Est (Jun-15) :-0.23
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):-3.65

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback